lupin

Advertisement
Forbes List Logo
We have to be the best in class on quality and compliance: Lupin's Nilesh Gupta
Why the pharma company is looking to focus on innovation and specialty products
ByNaini Thaker
Why are pharma giants looking to spin off their API business?
ByNaini Thaker
Regulatory scrutiny and pricing pressure is reducing profitability: Lupin's Ramesh Swaminathan
ByNaini Thaker
Desh Bandhu Gupta: The humble professor
ByAveek Datta
Lupin's Q2 FY16 net profit slips as US biz slows down
ByAveek Datta
Advertisement
Lupin's retail therapy
ByAveek Datta
Will Pharma Companies Have to Stop 'Gifting' Doctors?
ByNilofer D'Souza
Just what the Doctor Ordered
ByT Surendar
Advertisement
Advertisement
Advertisement

Latest News